Vaccinations for rheumatoid arthritis

Lisa M. Perry, Kevin Winthrop, Jeffrey R. Curtis

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Patients with rheumatoid arthritis (RA) suffer an increased burden of infectious disease-related morbidity and mortality and have twice the risk of acquiring a severe infection compared to the general population. This increased risk is not only a result of the autoimmune disease but is also attributed to the immunosuppressive therapies that are commonly used in this patient population. Given the increase in infection-related risks in RA, there is great interest in mitigating such risk. A number of vaccines are available to the rheumatologist, with a handful that are of importance for RA patients in the United States. The goal of this paper is to highlight the most recent literature on the key vaccines and the specific considerations for the rheumatologist and their RA patients, with a particular focus on influenza, pneumococcal, and herpes zoster vaccines. It is important for rheumatologist to understand and be aware of which vaccines are live and what potential contraindications exist for giving vaccines to RA patients.

Original languageEnglish (US)
Article number431
JournalCurrent Rheumatology Reports
Volume16
Issue number8
DOIs
StatePublished - 2014

Fingerprint

Rheumatoid Arthritis
Vaccination
Vaccines
Herpes Zoster Vaccine
Immunosuppressive Agents
Infection
Human Influenza
Population
Autoimmune Diseases
Communicable Diseases
Morbidity
Mortality
Rheumatologists
Therapeutics

Keywords

  • Biologics
  • DMARDs
  • Herpes zoster vaccination
  • Influenza
  • Pneumococcal vaccination
  • RA
  • Rheumatoid arthritis
  • Vaccination

ASJC Scopus subject areas

  • Rheumatology
  • Medicine(all)

Cite this

Vaccinations for rheumatoid arthritis. / Perry, Lisa M.; Winthrop, Kevin; Curtis, Jeffrey R.

In: Current Rheumatology Reports, Vol. 16, No. 8, 431, 2014.

Research output: Contribution to journalArticle

Perry, Lisa M. ; Winthrop, Kevin ; Curtis, Jeffrey R. / Vaccinations for rheumatoid arthritis. In: Current Rheumatology Reports. 2014 ; Vol. 16, No. 8.
@article{a8b6652d35074d8b949d3fdfe1a75b0c,
title = "Vaccinations for rheumatoid arthritis",
abstract = "Patients with rheumatoid arthritis (RA) suffer an increased burden of infectious disease-related morbidity and mortality and have twice the risk of acquiring a severe infection compared to the general population. This increased risk is not only a result of the autoimmune disease but is also attributed to the immunosuppressive therapies that are commonly used in this patient population. Given the increase in infection-related risks in RA, there is great interest in mitigating such risk. A number of vaccines are available to the rheumatologist, with a handful that are of importance for RA patients in the United States. The goal of this paper is to highlight the most recent literature on the key vaccines and the specific considerations for the rheumatologist and their RA patients, with a particular focus on influenza, pneumococcal, and herpes zoster vaccines. It is important for rheumatologist to understand and be aware of which vaccines are live and what potential contraindications exist for giving vaccines to RA patients.",
keywords = "Biologics, DMARDs, Herpes zoster vaccination, Influenza, Pneumococcal vaccination, RA, Rheumatoid arthritis, Vaccination",
author = "Perry, {Lisa M.} and Kevin Winthrop and Curtis, {Jeffrey R.}",
year = "2014",
doi = "10.1007/s11926-014-0431-x",
language = "English (US)",
volume = "16",
journal = "Current Rheumatology Reports",
issn = "1523-3774",
publisher = "Current Science, Inc.",
number = "8",

}

TY - JOUR

T1 - Vaccinations for rheumatoid arthritis

AU - Perry, Lisa M.

AU - Winthrop, Kevin

AU - Curtis, Jeffrey R.

PY - 2014

Y1 - 2014

N2 - Patients with rheumatoid arthritis (RA) suffer an increased burden of infectious disease-related morbidity and mortality and have twice the risk of acquiring a severe infection compared to the general population. This increased risk is not only a result of the autoimmune disease but is also attributed to the immunosuppressive therapies that are commonly used in this patient population. Given the increase in infection-related risks in RA, there is great interest in mitigating such risk. A number of vaccines are available to the rheumatologist, with a handful that are of importance for RA patients in the United States. The goal of this paper is to highlight the most recent literature on the key vaccines and the specific considerations for the rheumatologist and their RA patients, with a particular focus on influenza, pneumococcal, and herpes zoster vaccines. It is important for rheumatologist to understand and be aware of which vaccines are live and what potential contraindications exist for giving vaccines to RA patients.

AB - Patients with rheumatoid arthritis (RA) suffer an increased burden of infectious disease-related morbidity and mortality and have twice the risk of acquiring a severe infection compared to the general population. This increased risk is not only a result of the autoimmune disease but is also attributed to the immunosuppressive therapies that are commonly used in this patient population. Given the increase in infection-related risks in RA, there is great interest in mitigating such risk. A number of vaccines are available to the rheumatologist, with a handful that are of importance for RA patients in the United States. The goal of this paper is to highlight the most recent literature on the key vaccines and the specific considerations for the rheumatologist and their RA patients, with a particular focus on influenza, pneumococcal, and herpes zoster vaccines. It is important for rheumatologist to understand and be aware of which vaccines are live and what potential contraindications exist for giving vaccines to RA patients.

KW - Biologics

KW - DMARDs

KW - Herpes zoster vaccination

KW - Influenza

KW - Pneumococcal vaccination

KW - RA

KW - Rheumatoid arthritis

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=84902023331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902023331&partnerID=8YFLogxK

U2 - 10.1007/s11926-014-0431-x

DO - 10.1007/s11926-014-0431-x

M3 - Article

C2 - 24925587

AN - SCOPUS:84902023331

VL - 16

JO - Current Rheumatology Reports

JF - Current Rheumatology Reports

SN - 1523-3774

IS - 8

M1 - 431

ER -